Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Micron Shares Surge on Upgraded Outlook and Record Performance

Dieter Jaworski by Dieter Jaworski
January 3, 2026
in AI & Quantum Computing, Analysis, Nasdaq, Semiconductors, Tech & Software
0
Micron Stock
0
SHARES
37
VIEWS
Share on FacebookShare on Twitter

Micron Technology’s stock experienced a significant rally, climbing over 10% in a single session to establish a fresh 52-week peak at $315.42. This upward movement was catalyzed by a substantial price target revision from Bernstein, where analysts raised their projection from $270 to $330 per share. According to Bernstein’s Mark Li, the adjustment reflects sustained robust demand for High-Bandwidth Memory (HBM) used in artificial intelligence applications, coupled with favorable pricing trends in the DRAM market.

Strong Quarterly Results Underpin Confidence

The current market enthusiasm is firmly rooted in Micron’s exceptional financial report for its first fiscal quarter of 2026. The company posted revenue of $13.64 billion, a 57% year-over-year increase that handily surpassed the $12.62 billion consensus estimate. Adjusted earnings per share nearly tripled to $4.78, dramatically exceeding analyst forecasts of $3.77.

Key profitability metrics showed remarkable improvement. The gross margin expanded to approximately 57%, up from 25% previously. Furthermore, operating cash flow more than doubled, reaching $8.41 billion. CEO Sanjay Mehrotra highlighted that the total addressable market for HBM is now anticipated to hit $100 billion by 2028—two years ahead of prior expectations. This market was valued at roughly $35 billion in 2025.

Analyst Sentiment Turns Increasingly Bullish

Bernstein’s updated assessment joins a chorus of positive analyst commentary following Micron’s mid-December earnings release. Wolfe Research elevated its price target to $350. Bank of America upgraded the stock from “Neutral” to “Buy,” simultaneously raising its target from $250 to $300. Piper Sandler and Citigroup also issued upward revisions, with Citigroup establishing a new fair value estimate of $330.

Should investors sell immediately? Or is it worth buying Micron?

The consensus rating among 37 covering analysts remains a “Buy.” Recent target increases have pushed the average price target significantly higher from its previous level of $283. Trading activity intensified alongside the price surge, with volume hitting 41.9 million shares on Friday—about 62% above the three-month average.

Guidance Signals Continued Momentum

For the ongoing second fiscal quarter, Micron has provided an outlook that exceeds market expectations. The company forecasts revenue of $18.7 billion, representing sequential growth of 37%. It anticipates its gross margin will rise to 68%, with adjusted earnings per share climbing to $8.42.

Management noted that its entire HBM production capacity for calendar year 2026, including the next-generation HBM4, is already sold out. Bernstein’s Mark Li projects DRAM prices will increase between 20% and 25% in the second quarter. Micron’s own guidance suggests the company may possess even greater pricing power.

Investors are likely to focus on upcoming developments in HBM customer acquisitions and further DRAM market pricing trends ahead of the next quarterly report, expected in mid-March.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from March 25 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Micron: Buy or sell? Read more here...

Tags: Micron
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
Next Post
Barrick Stock

Barrick Gold Shares Surge Following a Landmark Fiscal Performance

Bloom Energy Stock

Fuel Cell Stocks Surge as Bloom Energy Secures Major Financing

Solana Stock

Solana's Crossroads: Robust Fundamentals Meet Market Headwinds

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com